Sympatient
Sympatient develops digital anxiety therapy.
Sympatient has raised €9.1M across 2 funding rounds from 2 investors, most recently a Series A round in Sep 2022. Based in Hamburg, Germany; founded 2017; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€9.1M
€9,100,000
Funding rounds
2
Investors
2
distinct backers
Active since
2020-05
latest 2022-09
Funding by year
EUR raised per yearSympatient — funding by year — interactive chart.
Data table
| Sympatient — funding by year | |
|---|---|
| 2020 | €1.6M |
| 2022 | €7.5M |
Signals
High confidenceRaise-next likelihood9
base rate 44% for Series A
- ▼ Past typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood8
base rate 11% (2+ rounds)
- ▲ 9y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-09-29 | Series A | €7.5M | Verve Ventures | View deal → |
| 2020-05-28 | Seed | €1.6M | Investiere | View deal → |
Investors
2Related news
Similar companies
same sector or country- Delivery Hero€7.1BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Helsing€2.9BGermany · AI
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
Global coverage: FundingData